Revenue Breakdown

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
COVID-19 Vaccine Revenue (Post-FY2023 Reporting)	1.93B	2.00B	2.43B
COVID-19 Vaccine Revenue (Post-FY2023 Reporting) Growth	-3.31%	-17.96%	-35.59%
Out-Licensing Revenue	-	613.00M	-
Other Sales Revenue (Post-FY2023 Reporting)	263.00M	261.60M	319.00M
Other Sales Revenue (Post-FY2023 Reporting) Growth	0.53%	-17.99%	645.33%
Revenue (Other)	643.40M	184.60M	140.60M
Revenue (Total)	2.84B	3.05B	2.89B
Revenue (Total) Growth	-7.17%	5.63%	-26.31%

Updated May 5, 2026. Data Source: Fiscal.ai.